EcoDrugPlus

Ensembl ID : ENSORLG00000022887
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSORLG00000024750
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSORLG00000026770
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSORLG00000026938
Gene Symbol: -
Cross references: -
156 Possible Orthologues:

Ensembl ID : ENSORLG00000028152
Gene Symbol: -
Cross references: -
104 Possible Orthologues:

Ensembl ID : ENSORLG00000024477
Gene Symbol: -
Cross references: -
428 Possible Orthologues:

Ensembl ID : ENSORLG00000022723
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSORLG00000022626
Gene Symbol: -
Cross references: -
429 Possible Orthologues:

Ensembl ID : ENSORLG00000025407
Gene Symbol: -
Cross references: -
375 Possible Orthologues:

Ensembl ID : ENSORLG00000022549
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSORLG00000022096
Gene Symbol: -
Cross references: -
429 Possible Orthologues:

Ensembl ID : ENSORLG00000016984
Gene Symbol: -
Cross references: -
177 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).